pharmalite limited
pharmalite limited Company Information
Company Number
08165320
Next Accounts
May 2025
Industry
Other human health activities
Directors
Shareholders
nasir ali & sophia zaman
Group Structure
View All
Contact
Registered Address
296 cavendish road, london, SW12 0PL
Website
www.pharmalite.co.ukpharmalite limited Estimated Valuation
Pomanda estimates the enterprise value of PHARMALITE LIMITED at £1.3m based on a Turnover of £2.8m and 0.47x industry multiple (adjusted for size and gross margin).
pharmalite limited Estimated Valuation
Pomanda estimates the enterprise value of PHARMALITE LIMITED at £772.7k based on an EBITDA of £208.3k and a 3.71x industry multiple (adjusted for size and gross margin).
pharmalite limited Estimated Valuation
Pomanda estimates the enterprise value of PHARMALITE LIMITED at £2.2m based on Net Assets of £874.5k and 2.47x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Pharmalite Limited Overview
Pharmalite Limited is a live company located in london, SW12 0PL with a Companies House number of 08165320. It operates in the other human health activities sector, SIC Code 86900. Founded in August 2012, it's largest shareholder is nasir ali & sophia zaman with a 100% stake. Pharmalite Limited is a established, small sized company, Pomanda has estimated its turnover at £2.8m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Pharmalite Limited Health Check
Pomanda's financial health check has awarded Pharmalite Limited a 4 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 4 areas for improvement. Company Health Check FAQs
4 Strong
2 Regular
4 Weak
Size
annual sales of £2.8m, make it larger than the average company (£667.5k)
- Pharmalite Limited
£667.5k - Industry AVG
Growth
3 year (CAGR) sales growth of 6%, show it is growing at a similar rate (5.7%)
- Pharmalite Limited
5.7% - Industry AVG
Production
with a gross margin of 21%, this company has a higher cost of product (37.3%)
- Pharmalite Limited
37.3% - Industry AVG
Profitability
an operating margin of 7.6% make it more profitable than the average company (5.7%)
- Pharmalite Limited
5.7% - Industry AVG
Employees
with 6 employees, this is below the industry average (17)
6 - Pharmalite Limited
17 - Industry AVG
Pay Structure
on an average salary of £25.3k, the company has an equivalent pay structure (£25.3k)
- Pharmalite Limited
£25.3k - Industry AVG
Efficiency
resulting in sales per employee of £459.9k, this is more efficient (£46.4k)
- Pharmalite Limited
£46.4k - Industry AVG
Debtor Days
it gets paid by customers after 129 days, this is later than average (23 days)
- Pharmalite Limited
23 days - Industry AVG
Creditor Days
its suppliers are paid after 80 days, this is slower than average (18 days)
- Pharmalite Limited
18 days - Industry AVG
Stock Days
There is insufficient data available for this Key Performance Indicator!
- Pharmalite Limited
- - Industry AVG
Cash Balance
There is insufficient data available for this Key Performance Indicator!
- - Pharmalite Limited
- - Industry AVG
Debt Level
it has a ratio of liabilities to total assets of 35.5%, this is a higher level of debt than the average (25.6%)
35.5% - Pharmalite Limited
25.6% - Industry AVG
PHARMALITE LIMITED financials
Pharmalite Limited's latest turnover from August 2023 is estimated at £2.8 million and the company has net assets of £874.5 thousand. According to their latest financial statements, Pharmalite Limited has 6 employees and maintains cash reserves of 0 as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
| Aug 2023 | Aug 2022 | Aug 2021 | Aug 2020 | Aug 2019 | Aug 2018 | Aug 2017 | Aug 2016 | Aug 2015 | Aug 2014 | Aug 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Turnover | |||||||||||
| Other Income Or Grants | |||||||||||
| Cost Of Sales | |||||||||||
| Gross Profit | |||||||||||
| Admin Expenses | |||||||||||
| Operating Profit | |||||||||||
| Interest Payable | |||||||||||
| Interest Receivable | |||||||||||
| Pre-Tax Profit | |||||||||||
| Tax | |||||||||||
| Profit After Tax | |||||||||||
| Dividends Paid | |||||||||||
| Retained Profit | |||||||||||
| Employee Costs | |||||||||||
| Number Of Employees | 6 | 7 | |||||||||
| EBITDA* |
* Earnings Before Interest, Tax, Depreciation and Amortisation
| Aug 2023 | Aug 2022 | Aug 2021 | Aug 2020 | Aug 2019 | Aug 2018 | Aug 2017 | Aug 2016 | Aug 2015 | Aug 2014 | Aug 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Tangible Assets | 344,652 | 358,843 | 374,235 | 391,377 | 333,222 | 282,127 | 1,120 | 1,494 | 1,992 | 928 | 1,237 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments & Other | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors (Due After 1 year) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Total Fixed Assets | 344,652 | 358,843 | 374,235 | 391,377 | 333,222 | 282,127 | 1,120 | 1,494 | 1,992 | 928 | 1,237 |
| Stock & work in progress | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Debtors | 980,157 | 792,538 | 598,234 | 304,123 | 176,016 | 123,670 | 94,017 | 31,820 | 0 | 0 | 0 |
| Group Debtors | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Misc Debtors | 30,035 | 30,035 | 20,035 | 20,165 | 0 | 0 | 0 | 0 | 0 | 103 | 0 |
| Cash | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 29 | 3,419 | 4,675 | 2,964 |
| misc current assets | 0 | 0 | 0 | 0 | 0 | 0 | 8,198 | 0 | 0 | 0 | 0 |
| total current assets | 1,010,192 | 822,573 | 618,269 | 324,288 | 176,016 | 123,670 | 102,215 | 31,849 | 3,419 | 4,778 | 2,964 |
| total assets | 1,354,844 | 1,181,416 | 992,504 | 715,665 | 509,238 | 405,797 | 103,335 | 33,343 | 5,411 | 5,706 | 4,201 |
| Bank overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Bank loan | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Trade Creditors | 478,210 | 460,472 | 468,687 | 384,271 | 384,129 | 380,383 | 72,706 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other short term finances | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other current liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 33,001 | 5,267 | 5,705 | 3,884 |
| total current liabilities | 478,210 | 460,472 | 468,687 | 384,271 | 384,129 | 380,383 | 72,706 | 33,001 | 5,267 | 5,705 | 3,884 |
| loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| hp & lease commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | 2,175 | 2,683 | 2,683 | 2,633 | 2,450 | 0 | 50 | 0 | 0 | 0 | 0 |
| other liabilities | 0 | 0 | 0 | 873 | 0 | 1,300 | 0 | 0 | 0 | 0 | 0 |
| provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| total long term liabilities | 2,175 | 2,683 | 2,683 | 3,506 | 2,450 | 1,300 | 50 | 0 | 0 | 0 | 0 |
| total liabilities | 480,385 | 463,155 | 471,370 | 387,777 | 386,579 | 381,683 | 72,756 | 33,001 | 5,267 | 5,705 | 3,884 |
| net assets | 874,459 | 718,261 | 521,134 | 327,888 | 122,659 | 24,114 | 30,579 | 342 | 144 | 1 | 317 |
| total shareholders funds | 874,459 | 718,261 | 521,134 | 327,888 | 122,659 | 24,114 | 30,579 | 342 | 144 | 1 | 317 |
| Aug 2023 | Aug 2022 | Aug 2021 | Aug 2020 | Aug 2019 | Aug 2018 | Aug 2017 | Aug 2016 | Aug 2015 | Aug 2014 | Aug 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Activities | |||||||||||
| Operating Profit | |||||||||||
| Depreciation | 498 | 664 | 309 | 413 | |||||||
| Amortisation | 0 | 0 | 0 | 0 | |||||||
| Tax | |||||||||||
| Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Debtors | 187,619 | 204,304 | 293,981 | 148,272 | 52,346 | 29,653 | 62,197 | 31,820 | -103 | 103 | 0 |
| Creditors | 17,738 | -8,215 | 84,416 | 142 | 3,746 | 307,677 | 72,706 | 0 | 0 | 0 | 0 |
| Accruals and Deferred Income | -508 | 0 | 50 | 183 | 2,450 | -50 | -32,951 | 27,734 | -438 | 1,821 | 3,884 |
| Deferred Taxes & Provisions | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash flow from operations | |||||||||||
| Investing Activities | |||||||||||
| capital expenditure | |||||||||||
| Change in Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| cash flow from investments | |||||||||||
| Financing Activities | |||||||||||
| Bank loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Group/Directors Accounts | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Short Term Loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long term loans | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Hire Purchase and Lease Commitments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| other long term liabilities | 0 | 0 | -873 | 873 | -1,300 | 1,300 | 0 | 0 | 0 | 0 | 0 |
| share issue | |||||||||||
| interest | |||||||||||
| cash flow from financing | |||||||||||
| cash and cash equivalents | |||||||||||
| cash | 0 | 0 | 0 | 0 | 0 | 0 | -29 | -3,390 | -1,256 | 1,711 | 2,964 |
| overdraft | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| change in cash | 0 | 0 | 0 | 0 | 0 | 0 | -29 | -3,390 | -1,256 | 1,711 | 2,964 |
pharmalite limited Credit Report and Business Information
Pharmalite Limited Competitor Analysis
Perform a competitor analysis for pharmalite limited by selecting its closest rivals, whether from the HUMAN HEALTH AND SOCIAL WORK ACTIVITIES sector, other small companies, companies in SW12 area or any other competitors across 12 key performance metrics.
pharmalite limited Ownership
PHARMALITE LIMITED group structure
Pharmalite Limited has no subsidiary companies.
Ultimate parent company
PHARMALITE LIMITED
08165320
pharmalite limited directors
Pharmalite Limited currently has 1 director, Mr Nasir Ali serving since Aug 2012.
| officer | country | age | start | end | role |
|---|---|---|---|---|---|
| Mr Nasir Ali | England | 40 years | Aug 2012 | - | Director |
P&L
August 2023turnover
2.8m
+22%
operating profit
208.3k
0%
gross margin
21.1%
-2.03%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
August 2023net assets
874.5k
+0.22%
total assets
1.4m
+0.15%
cash
0
0%
net assets
Total assets minus all liabilities
pharmalite limited company details
company number
08165320
Type
Private limited with Share Capital
industry
86900 - Other human health activities
incorporation date
August 2012
age
12
incorporated
UK
ultimate parent company
accounts
Micro-Entity Accounts
last accounts submitted
August 2023
previous names
N/A
accountant
CBS ACCOUNTANTS LTD
auditor
-
address
296 cavendish road, london, SW12 0PL
Bank
-
Legal Advisor
-
pharmalite limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We did not find charges/mortgages relating to pharmalite limited.
pharmalite limited Companies House Filings - See Documents
| date | description | view/download |
|---|
